Finance

Lists
Why is 1541 up 2,58%?
Dive Deeper
1541:HKG
ImmuneOnco Biopharmaceuticals(Shngh) Inc
HK$2,98
+2,58%
(+0,075) 1D
16 Okt., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1541...
Open
HK$2,98
High
HK$3,07
Low
HK$2,92
Mkt. cap
1,28 mjd
Avg. vol.
385,40 k
Volume
273,40 k
52-wk high
HK$11,90
52-wk low
HK$2,80
EPS
-HK$0,63
No. of employees
197
Open
HK$2,98
High
HK$3,07
Low
HK$2,92
Mkt. cap
1,28 mjd
Avg. vol.
385,40 k
Volume
273,40 k
52-wk high
HK$11,90
52-wk low
HK$2,80
EPS
-HK$0,63
No. of employees
197
News stories
From web sources and news partners
About ImmuneOnco Biopharmaceuticals(Shngh) Inc
CEO-
Employees197
Founded2015
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
55,14 m
55,14 m
18,62 m
18,62 m
Cost of goods sold
555,00 k
555,00 k
-
-
Cost of revenue
555,00 k
555,00 k
-
-
Research and development expenses
77,12 m
77,12 m
77,39 m
77,39 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,34 m
13,34 m
11,60 m
11,60 m
Operating expense
90,46 m
90,46 m
88,99 m
88,99 m
Total operating expenses
91,01 m
91,01 m
88,99 m
88,99 m
Operating income
-35,87 m
-35,87 m
-70,36 m
-70,36 m
Other non operating income
4,90 m
4,90 m
-6,50 k
-6,50 k
EBT including unusual items
-33,27 m
-33,27 m
-82,74 m
-82,74 m
EBT excluding unusual items
-33,47 m
-33,47 m
-77,67 m
-77,67 m
Income tax expense
14,50 k
14,50 k
11,50 k
11,50 k
Effective tax rate
-0,04%
-0,04%
-0,01%
-0,01%
Other operating expenses
-
-
-
-
Net income
-33,00 m
-33,00 m
-82,09 m
-82,09 m
Net profit margin
-59,84%
-59,84%
-440,81%
-440,81%
Earnings per share
-
-
-
-
Interest and investment income
1,57 m
1,57 m
2,28 m
2,28 m
Interest expense
-1,43 m
-1,43 m
-2,12 m
-2,12 m
Net interest expenses
136,00 k
136,00 k
165,50 k
165,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-33,84 m
-33,84 m
-68,41 m
-68,41 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme